Company intelligence / Profile preview
Epsilon Biotech
- Ownership
- Private
- Employees
- ~50
- Development stage
- Other
Overview
Epsilon Biotech is an Indian pharmaceutical company established in 2010 and headquartered in Kala Amb, Himachal Pradesh. The company operates as a WHO & GMP certified PCD (Propaganda Cum Distribution) Pharma Franchise and third-party manufacturer. Epsilon Biotech offers a diverse portfolio of high-quality, affordable medicines across multiple therapeutic categories, including antibiotics, analgesics, gynecology, orthopedics, and dermatology. Its product range spans tablets, capsules, softgels, syrups, injectables, and topical formulations distributed PAN India.
- Therapeutic areas
- Women's HealthImmunologyDermatologyInfectious DiseasesNeurologyMetabolic Disorders
- Modalities
- Small moleculeBotanical extractPeptidesProtein
- Industry
- Pharma
Drug pipeline
1 assetBeyond the preview
Go deeper on Epsilon Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Epsilon Biotech.